An association of gout with elevated levels of plasma lipids is well documented (Barlow, 1968; Berkowitz, 1964; Feldman and Wallace, 1964) . Conversely, patients with primary hyperlipoproteinaemia often have a raised plasma urate (Harris-Jones, 1957) and occasionally develop secondary gout (Strejcek and Kucerova, 1969) .
The mechanism of this interrelationship is not known but, as there is also evidence of a link between hyperuricaemia and ischaemic heart disease (Dawber, Moore, and Mann, 1957) , its elucidation is of practical importance in preventive medicine.
We report on a family, originally described in 1960 (Duncan and Dixon, 1960) with familial hyperuricaemia, two members of which have had gouty arthritis; several members have now been found to have hypertriglyceridaemia.
Family history (see Figure and Table) In the family, as originally described, both parents had hyperuricaemia (but never suffered from gout) and all six surviving children had hyperuricaemia. Two of the brothers (116 and 7) subsequently died, at the ages of 22 and 25 years respectively, of renal failure, thought to be secondary to their hyperuricaemia. The eldest sister (I1) died at the age of 16 in renal failure and it is presumed that she too had severe hyperuricaemia; the histology of her kidneys supported this assumption. Her brother (115) (Cramp and Robertson, 1968) and lipoprotein electrophoresis was performed on cellulose acetate (Chin and Blankenhorn, 1968) . In the intravenous fat tolerance test, 0-1 g. triglyceride per kg. body weight was injected intravenously in the form of 'Intralipid' (Vitrum, Stockholm, batch No. 191249) , and its disappearance from the plasma was measured nephelometrically over the course of 40 minutes (Lewis, Boberg, Mancini, and Carlson, 1972) . The rate constant for the disappearance curve, K2, gives a measure of the fractional turnover rate of triglyceride. The normal K2 value for men is 0-056 ± 0-016 min-I (mean ± S.D.) (Lewis and Chait, unpublished data; Lewis, Sissons, and Chait, unpublished data) . (Fredrickson, Levy, and Lees, 1967) .
Although in general the relationship of gout to raised serum lipids is not known, there are two situations, namely glycogen storage disease Type 1 and over-indulgence in alcohol, in which common biochemical pathways have been proposed: in glycogen storage disease, the deficiency of glucose-6-phosphatase leads to an intracellular accumulation of glucose-6-phosphate. This acts as a substrate for de novo purine synthesis via the pentose shunt pathway; thus leading to an overproduction of both uric acid and fatty acids (Jakovcic and Sorensen, 1967) .
In excess alcohol consumption, the alcohol is thought to be oxidized in preference to fatty acids within the liver resulting in decreased levels of NAD. Consequently, an excess of fatty acids is available for triglyceride formation. In addition, the excess of available hydrogen atoms from NADH2 favours the conversion of pyruvate to lactate, the resulting acidosis leading to hyperuricaemia by its inhibition of renal urate secretion (Lieber, 1965) .
Although not numerically important in the context of the interrelationship of gout to lipid metabolism, these two diseases provide some insight into possible mechanisms of common biochemical pathways.
The low values found in the intravenous fat tolerance tests in these patients suggests that a decreased rate of triglyceride removal is of importance in the pathogenesis of the raised lipid levels. This might occur as a result of a deficiency of lipoprotein lipase activity, or from a defective triglyceride resynthesis within the cell (Fredrickson and others, 1967 ).
It appears from the family reported here that a genetic component to this association can occur, thus providing an incentive to search for possible common enzyme deficiencies. The actual inheritance of the 29 hyperuricaemia and the hypertriglyceridaemia in this family cannot be explained in simple Mendelian terms, although it is of interest that the hypertriglyceridaemia has only been passed on by the females. However, I114, 1115, 1118, and 1119 are not yet old enough to exclude the possibility of their developing hyperlipidaemia or hyperuricaemia.
Patient II8, who was started on treatment at the age of 12 and has been normouricaemic since that time, has pronounced hypertriglyceridaemia. It thus appears that hyperuricaemia does not play a direct role in the genesis of the raised lipid levels. This is supported by the finding that a therapeutic reduction of plasma urate does not regularly alter the lipid abnormalities in gout (Bluestone, Lewis, and Mervart, 1971) .
Hyperuricaemia, usually of mild degree, is a recognized feature of familial preB-hyperlipoproteinaemia, but this association is unlikely to account for the severely elevated urate levels and the chronic renal failure seen in this family. About one-third of patients with chronic renal failure due to primary renal disease have hypertriglyceridaemia, usually of moderate degree (Bagdade, 1970) ; in many but not all of these, the high carbohydrate content of the therapeutic diet may largely explain the hypertriglyceridaemia, on the basis of carbohydrate-induced lipaemia; however, three patients in the family have hypertriglyceridaemia despite normal urea levels and an unmodified diet.
It is also possible that in some cases the familiar relationship between gout and alcohol plays a role in elevating the lipid levels in these patients (Chait, Mancini, February, and Lewis, 1972 
